In a 24 week Phase 3 randomised double-blind placebo-controlled trial in drug-naive individuals with type 2 diabetes, dorzagliatin lowered HbA 1c by ~0.6 mmol/mol (0.57%
Faster, more complete absorption from the abdomen means more predictable blood levels and more consistent results
aleniglipron Structure Therapeutics is testing this small-molecule oral GLP-1
Less Common Side Effects Although individual responses may vary, research to date suggests that retatrutide may be associated with fatigue, headache, general gastrointestinal reactivity, and allergic-type reactions in some cases
By providing clear explanations of how different factors influence dosing, patients can become more engaged in their treatment plans
Medical information is protected and confidential, so you dont have to share your choices unless you choose to